Mounjaro Maker Eli Lilly Jumps In Quality Despite Trump-Fueled Price Cut Fears

Eli Lilly and Co. (NYSE:LLY) has surged into the top decile of quality rankings among S&P 500 peers, achieving a percentile score of 90.25 on the latest composite quality report, despite fresh uncertainty surrounding the future pricing of its blockbuster weight loss drug, Mounjaro.Check out LLY stock price here. Trump Drug Price Reduction Threat Keeps LLY Quality UnfazedThe pharmaceutical giant's climb in operational and financial quality arrives as President Donald Trump pledges to drive "fat-loss drug" pr ...